Metatranscriptomic sequencing of 403 Antarctic samples has uncovered 58 RNA viruses, most of them new to science, with ...
Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...
MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life science, launched ...
Prioritize recurring consumables, AI analytics, FFPE-compatible automation and end-to-end workflows; target oncology, research institutes and CRO partnerships.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ...
The W. M. Keck Foundation has awarded $1.3 million to the University of California San Diego to support an ambitious research ...
CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Cerenome), announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to ...
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery ...
TychoBio will test candidate RNA therapies across multiple cell types and use PacBio sequencing to measure changes in the transcriptome following treatment. The resulting data will be used to train ...
On Tuesday, Pacific Biosciences of California, Inc. (PACB), a developer of advanced sequencing technologies, and TychoBio, an AI drug discovery company, announced a collaboration to generate ...
Pacific Biosciences of California launches collaboration with tychobio_ai to generate RNA data for AI-driven therapeutics in rare disease.
Pacific Biosciences of California (PACB) and AI drug discovery company TychoBio have agreed to generate full-length RNA data that will be used by TychoBio to train AI models for RNA therapy design, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results